I took my Phase 1 completion date from the NIH Clinical Trial register (ClinicalTrials.gov Identifier: NCT02923375). Possibly Japan may take some different route.
It is something of a sweeping statement that GVHD won't be a money maker - there is a wider picture here around the whole inflammation area.
A 'different method' of MSC production doesn't mean that they won't infringe patents. It will be interesting to see how it plays out.
That's me done. In fact, not sure I will read, or post on, hotcopper again. It has been disappointing to have to wade through literally hundreds of trivial emails to find those with something to say. No, I don't have this one from berad in mind, but certain other voluminous 'contributors'.
MSB Cells Enter Europe!, page-25
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.055(4.66%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $4.824M | 4.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25589 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |